Return
A stimuli-responsive hydrogel that targets myeloid differentiation primary response 88 signaling in the foreign body response
E
B
C
D
S
DOI:10.1016/j.jconrel.2026.115225.png)
Abstract
En 中文
• A new stimuli-responsive hydrogel is developed to target inflammatory macrophages. • Release of MyD88 inhibitor is controlled by an MMP-12 linker. • The released inhibitor product is taken up by macrophages and retains its bioactivity. • The therapeutic hydrogel inhibits the foreign body response in a mouse model.
Journal
IF:
11.5
Papers:
1.5W
Citations:
7.4W
